Updated Jul 16, 2026
Chernett Jorey has filed 10 SEC Form 4 filings across 3 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $8.79M. Lifetime open-market sales: $7K. Historical track record: 5/5 stars across 29 tracked purchases.
Chernett Jorey is identified as a 10% owner of Airsculpt Technologies, Inc. based on the most recent SEC filing dated March 4, 2026. There is limited publicly available information regarding their background or career achievements.
| Role | 10% Owner |
|---|---|
| Notability | 10/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★★ (5/5) |
|---|---|
| Total purchases tracked | 29 |
| Purchases with forward-return data | 29 |
| 30-day win rate | 6897% |
| 90-day win rate | 7931% |
| Avg 5-day return | +420.59% |
| Avg 30-day return | +1411.73% |
| Avg 90-day return | +6438.28% |
| Best 30-day return | +8270.89% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-15 | STIM | Neuronetics, Inc. | P — Open-market purchase | 35.0K | $1.78 | $62K |
| 2026-07-13 | TOI | Oncology Institute, Inc. | P — Open-market purchase | 15.0K | $5.85 | $88K |
| 2026-06-24 | TOI | Oncology Institute, Inc. | P — Open-market purchase | 18.0K | $5.02 | $90K |
| 2026-06-05 | TOI | Oncology Institute, Inc. | P — Open-market purchase | 12.0K | $4.75 | $57K |
| 2026-05-21 | TOI | Oncology Institute, Inc. | P — Open-market purchase | 33.5K | $4.07 | $136K |
| 2026-05-21 | TOI | Oncology Institute, Inc. | P — Open-market purchase | 5.0K | $4.05 | $20K |
| 2026-05-20 | STIM | Neuronetics, Inc. | P — Open-market purchase | 100.0K | $1.17 | $117K |
| 2026-05-20 | TOI | Oncology Institute, Inc. | P — Open-market purchase | 30.0K | $4.09 | $123K |
| 2026-05-13 | STIM | Neuronetics, Inc. | P — Open-market purchase | 475.0K | $1.34 | $636K |
| 2026-04-22 | STIM | Neuronetics, Inc. | P — Open-market purchase | 100.0K | $1.51 | $151K |
| 2026-04-22 | STIM | Neuronetics, Inc. | P — Open-market purchase | 100.0K | $1.58 | $158K |
| 2026-04-20 | AIRS | Airsculpt Technologies, Inc. | P — Open-market purchase | 40.0K | $2.54 | $102K |
| 2026-04-15 | AIRS | Airsculpt Technologies, Inc. | P — Open-market purchase | 20.0K | $2.60 | $52K |
| 2026-04-13 | TOI | Oncology Institute, Inc. | P — Open-market purchase | 20.0K | $3.10 | $62K |
| 2026-04-08 | AIRS | Airsculpt Technologies, Inc. | P — Open-market purchase | 60.0K | $2.93 | $176K |
| 2026-04-06 | AIRS | Airsculpt Technologies, Inc. | P — Open-market purchase | 90.0K | $2.82 | $254K |
| 2026-03-30 | TOI | Oncology Institute, Inc. | P — Open-market purchase | 27.4K | $2.96 | $81K |
| 2026-03-30 | STIM | Neuronetics, Inc. | P — Open-market purchase | 500.0K | $1.35 | $675K |
| 2026-03-27 | TOI | Oncology Institute, Inc. | P — Open-market purchase | 50.0K | $3.15 | $158K |
| 2026-03-27 | STIM | Neuronetics, Inc. | P — Open-market purchase | 25.0K | $1.44 | $36K |
Chernett Jorey is identified as a 10% owner of Airsculpt Technologies, Inc. based on the most recent SEC filing dated March 4, 2026. There is limited publicly available information regarding their background or career achievements.…
10 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 42 open-market purchases ($8.79M) and 1 open-market sales ($7K) across all tracked filings.
Across 29 tracked purchases, Chernett Jorey averaged +1411.7% avg 30-day return with a 6897% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Chernett Jorey profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.